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Several diverse metabolic events become compromised when mammalian cells arc made deficient in essential amino acids or when charging of their 
tRNA is blocked by amino acid analogs. This rapid general demise of ccl1 funclion ran be due ta inhibition of phosphofructokinase (PFK) by 
uncharged tRNA. It has now been demonstrated that when tRNA is added to PFK in an assay dcpendcnt upon the reassociation of inactive. 
dissociated enzyme subunits, nanomolar concentrations cause complctc inhibition. The model for control stiggests that charged tRNA becomes 
associated with EF-I, ujhich is specific for imiinoacyl-tRNAs nnd is present in sufficiently high concentrations in cells to squester thecharged forms 
from an inhibitory role. Support for this model include: (I ) the rapid onset of inhibition ofglycolysisand glucose uptake upon amino acid deficiency; 
(2) the unique role of the product of PFK activity, fructose-l ,6-diphosphate. in rcdclionsofpeplidc chuin initiation, particularly its roleasa co-factor 
for purified elF-?;B, the GDIVGTP exchange factor; (3) the correlations of this inlcraction with the cellular and molecular lesions of insulin 
insufficiency; (4) the rccoynition that the tinomnlous role of high concentrations ofcAMPas a stimulant of peptidechain i itiation in cncrgydepleted 
or gel-filtered cell lysatcs correlates with its stimulatory action on PFK as an analog for the positive flector. adenosinc-5’-monophosphate; and 
(5) the role of fructose-l,6-diphosphutc in the formation of glyccraldchydc-3.phosphate. a substrate for synthesis of ribose-S-phosphate via the 
non-oxidativc portion or the pentosc phosphate pathway. which. as P precursor of phosphoribosylpyrophosphate. is csrntial for nucleic acid 
synthesis. 
Amino acid deiiciency: tRNA; Aminoacyl-tRNA: Plrosphofructokinase; Fructose-1.6.diphosphatc; Insulin: Cyclic AMP 
1. INTRODUCTLON 
Several investigators [l-3] have observed that deple= 
tion of essential amino acids in mammalian cells initi- 
ales the rapid inhibition of a series of diverse metabolic 
events, termed by Hershko et al. [l] the ‘Pleiotypic Re- 
sponse’. Processes uch as glucose uptake, nucleic acid 
synthesis, and of course, protein synthesis are rapidly 
compromised. The latter process, studied intensively for 
the last 20 years, has yielded a series of consistent obser- 
vations, specifically, that in cells other than reticulo- 
cytes, amino acid deficiency or inhibition of tRNA acyl- 
ation causes abreakdown of the peptide chain initiation 
mechanism and a resulting disaggregation of potyri- 
bosomes [4]. Data has been presented that this event is 
the result of inhibition of phosphofructokinase (PFK) 
by uncharged tRNA [5]. In this communication a hy- 
pothesis further supporting this mechanism is described 
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with references to the literature which bring into closer 
focus the relationship between these two processes. 
2. ENERGY METABOLISM AND INHIBITION 
OF PHOSPHOFRUCTOKINASE BY tRNAPhc 
In the earlier report [S] differences in energy metabo- 
lism between several cell types ‘and reticulocytes were 
presented as the basis for the disparity in the sites of 
inhibition in protein synthesis found upon amino acid 
deprivation, at peptide chain initiation and elongation, 
respectively. It indicated that a major block in glycolysis 
and glucose uptake by Ehrlich ascites tumor cells in 
amino acid deficiency had already been reported [6]. 
Data was presented that this was due to inhibition of 
PFK by uncharged tRNA, a condition which would 
cause accumulation of glucose&phosphate, a potent 
inhibitor of hexokinase which promotes glucose uptake 
by phosphorylation. Inhibition of PFK by uncharged 
tRNA has now been confirmed with the use of yeast 
phenylanalinc tRNA, (tRNAPh’) and rabbit muscle 
PFK, assayed by following reassociation of inactive 
dimers to the active tetramer (Fig. 1). Such interaction 
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Fig. I. Inhibition of rcussociation dcpsndent uctivily of diasociatcd 
phosphofructokinvsc (PFK) by tRNA”‘“. Crystulline rabbit muscle 
phosphofructokinase obtained from Signa was dissolved in BESME 
[.5] a; L curlcentration of 200 PM (estinlilted as monomcrs OT M.Wl, 
85.000) and stored ut -20°C. Prior IO USC it was thawed d diluted 
lOIll)-fold in a solution of BES buffer, 0.05 M. pH 7, I containing 50% 
glycerol and 5 IIIM dithiothrcitol. This was dilulod into an cquill 
volu~ne of WLIL’I’ without or with ycas~ phcnylwnalinc tRNA (Boehrin- 
ger Munnheim) to yield tin4 concentuions ol’ 30 nM to that illus- 
trated. 100 IIM. Aliquots of this inter&on mixture wcrc added to an 
usmy system previously described [S] contuininp :! mM ATP and now 
fortified with 5 mM potassium phosphutc and ummoniun~ sullbtc. Ths 
rate ofoxidation ol’NADH wus recorded with rcudinys ofthccuvrttcs 
containing tRNA”” offset to prevent ovcrlappiny of rccordcd rats. 
Since complete dissociation of PFK was not achieved during the IO 
min internciion period, und irreversihlc inuctivation occurs with pro- 
longed incubation [IO] residual octivc PFK tctramrr was present in 
both control unrl tRNA”‘” intcrxting systems, Such activity is shown 
by the initial 6 min ri\tC of NADH oxidation in both control and 
inhibited In the syslcm IO0 tRNA”‘” 
the rate was prcscrvcd. indicating no reassociaion depondcnt 
activity occurred, thus corrcspondiny to 100% inhibition. A 50% inhi- 
bition was cslimatcd I’or interaction 01’ PFK with 25 nM tRYA”‘“. 
between the oligomeric forms of the enzyme has been 
proposed to represent one molecular mechanism for 
physiological control [7-91. 
3. SEQUESTRATION OF AMINOACYL-tRNA 
FROM INHIBITION OF PHOSPHOFRUCTO- 
KINASE 
As indicated recently by Zhao et a!. [IO] a wide variety 
of proleins inactivate PFK by interacting with exposed 
groups of the inactive enzyme dimer and preventing 
their reassociation to the active tetramer. It is therefore 
unlikely that PFK can discriminate between uncharged 
tRNA (of amino acid deprivation) and uminoacyl- 
tRNA (of amino acid sufficiency). The only known dis- 
criminatory agent with this property is peptide chain 
elongation factor ‘r (EP-‘r ). also described as EF-tu in 
prokaryotic systems [ 1 I]. This factor, when associated 
with GTP forms a stable ternary complex, aminoacyl- 
tRNA:EF-I :GTP, whose affinity for the aminoacylated 
II4 
form oftRNA is over 2000 times that for the unacylated 
variety [!2]. Also the quantity OF the factor in both 
prokaryotic [ 131 and eukaryotic [ 141 systems is suffi- 
ciently abundant for binding available charged tRNA. 
Thus the high specificity, affinity and capacity of this 
elongation factor for aminoacyl-tRNA makes it likely 
that the charged species is complexed within the cell 
and, when sequcnstered as part of the protein synthetic 
apparatus, is removed From an Inhibitory role towards 
PFK. 
4. MOLECULAR LESION OF AMINO ACID, 
FRUCTOSE-1,6-DIPHOSPHATE AND INSU- 
LIN INSUFFICIENCIES 
The locus of the lesion in peptide chain initiation. a 
decrease in the ternary complex. GTP-eIF2-initiator 
methionyl-tRNA bound to the small ribosomal subunit, 
appears identical under conditions of amino acid dcfi- 
ciency [ 151 or fructose-l .ddiphosphate omission from 
gel filtered lysates [!6]. The same pattern is observed 
during insulin insufficiency in diabetic muscle [!7]. This 
hormone had been reported to have a positive pleiotypic 
effect, stimulating many diverse metabolic functions [I]. 
One of its earliest activities is to stimulate PFK activity 
in the absence of enzyme synthesis [!8]. Such stimula- 
tion results in increases in the cellular concentration of 
fructose- 1,6-diphosphate [ i9], a specific positive effec- 
tor of purified eIF-23 [20], the GDP-GTP exchange 
factor, also termed GEF. This factor is required to re- 
move GDP from its associated factor, eIF-2 [21]. It thus 
permits the recycling of eIF-2 to Form the tertiary inia- 
Lion complex with GTP and the initiator tRNA, Met- 
tRNA, and to bind it to the small ribosomal subunit, 
Harmon et al. [22] have shown that eIF-2 will ovcrcomc 
the biochemical esion of insulin insufficiency when 
added to cell-Fret extracts of diabetic muscle. This sug- 
gests that when the initial supply of eIF-2 is prevented 
from recycling by blocked elF-25, additional material 
can support the peptide chain initiation step. Furthel 
support For this molecular mechanism derives from the 
observations that mixtures of amino acids promote the 
activity of administered insulin in muscle [23] and adi- 
pocytes [24]. They are consistent with the view that 
uncharged tRNAs limit the activity of PFK, and 
thereby reduce the full potential of insulin as a stimulant 
of this enzyme. 
5. CYCLIC AMP AS A STIMULANT OF PEPTIDE 
CHAIN 1NlTIATION AND PHOSPHOFRUC- 
TOKINASE 
Giloh and Mager [25] recognized that high concentra- 
tions of cyclic: AMP, ill the millimolar 1~11ge, markediy 
stimulated initiation of protein synthesis in lysates of 
rabbit reticulocytes which had been depleted of their 
ATP content by prolonged anaerobic incubation. They 
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Fig. 1. Diagrunmatic outline ol’interxting clTcctors, Brood urows 
with internal arrows. stimulation, Broad arrows with XX. inhibition, 
showed that phosphodicsterase, which converts cyclic 
AMP to linear udenosinc-S-monophosphate. did not 
interfere with this activity, Similar stimulations were 
observed when such high concentrations of cyclic AMP 
were added to gel filtered lysates [26,27]. The latter 
authors state ‘the high concentrations required (of cy- 
clic AMP) would seem to rule out any direct involve- 
ment.... in the normal regulatory process but one might 
speculate that it is acting as analogue of some small 
molecule which is directly involved’. This speculation 
appears to be correct. Cyclic AMP has long been recog- 
nized to act as an analog of linear adenosine-S-mono- 
phosphate [283 at the higher concentrations correspond- 
ing to physiological levels of the linear compound, a 
positive effector of phosphofructokinase. The observa- 
tion of Giloh and Mager, cited above, that added 
phosphodiesterase did not block the action of cyclic 
AMP supports this conclusion. 
6. PHOSPHOFRUCTOKINASE AND NUCLEIC 
ACID SYNTHESIS 
It has been earlier noted that when cells are in the 
amino acid deficient state they rapidly exhibit inhibition 
of nucleic acid biosynthesis [l-3,24]. This may occur 
even before there is a significant decrease in ATP con- 
tent. The cause for this has been shown by Boss and 
coworkers [30] to be due to a decrease in the concentra- 
tion of phosphoribosylpyrophosphate (PRPP) the sub- 
strate which introduces ribose into the de novo synthe- 
sis of purine and pyrimidine nucleotides. The quantity 
of the immediate precursor or PRPP, ribose-5-phos- 
phate, is also decreased [31]. This key compound, the 
source of all ribose and deoxyribose in newly formed 
RNA and DNA is synthesized in cells from glucose-6- 
phosphate via the pentose phosphate pathway (for an 
outline of this pathway see [32]). This route utilizes 
glyceraldehyde-3-phosphate in its non-oxidative por- 
tion, which in tumor cells comprises over 80 percent of 
the ribose synthetic potential [33]. Since the precursor 
of glyceraldchyde-3-phosphate in the glycolytic path- 
way is fructose-l,ddiphosphate, inhibition of PFK by 
uncharged tRNA would reduce its level in cells, rapidly 
depleting ribose-5-phosphate, phosphoribosylpyro- 
phosphate, and resulting in nucleic acid synthesis. 
Fig. 2 summarizes several of the cellular biochemical 
and molecular interactions described. Additional analy- 
sis and experimentation to challenge or support this 
wide ranging control system is needed. 
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